Stock listing

Tokyo:4597 Solasia Pharma KK (ソレイジア・ファーマ) 株価

Home listing (Tokyo) of Solasia Pharma KK

Follow Solasia Pharma KK into a list and get an email when it puts out news.

Solasia Pharma KK logo
Ticker
Tokyo:4597
Asset type
Stock
Exchange
Tokyo
Currency
JPY

What changed lately

Latest news

Consolidated Financial Results for the Six Months Ended June 30, 2026 (Under IFRS)

Aug 13, 2026

Solasia Announces Launch of Darvias® in Japan

Aug 22, 2022

Solasia Pharma KK: Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2022 (under IFRS)

Aug 15, 2022

Solasia Pharma K K Announces Topline Data from Phase III AGENT Study of SP-05(arfolitixorin)

Aug 3, 2022

Solasia Pharma K K Announces Capital and Business Alliance with Nippon Kayaku Co., Ltd.

Jun 28, 2022

Solasia Pharma: DARVIAS® Injection 135mg (Generic Name: DARINAPARSIN /Development Code: SP-02) Approved in Japan

Jun 19, 2022

Solasia Pharma K K Announces Finance via Issuance of Unsecured Straight Bond and Warrant

Feb 14, 2022

Consolidated Financial Results for the Nine Months of the Fiscal Year Ending December 31, 2021 (under IFRS)

Nov 10, 2021

Solasia Announces Revision to Full-Year Earnings Forecast

Nov 10, 2021

Solasia Pharma KK: Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2021 (under IFRS)

Aug 11, 2021

All Solasia Pharma KK news

Solasia Pharma KK on 6ix

News releases
1 in the last 12 months · 16 in all · newest Aug 13, 2026 · oldest 2021

Where Solasia Pharma KK is listed

ListingExchangeCountryCurrency
Tokyo:4597 ソレイジア・ファーマ · Home listing · This pageTokyoJapanJPY
LS Exchange:A2DN9SLS ExchangeGermanyEUR
Lang & Schwarz:A2DN9SLang & SchwarzGermanyEUR
Frankfurt:9SOFrankfurtGermanyEUR
Stuttgart:9SOStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Solasia Pharma KK.